Product/Composition:- | Divalproex |
---|---|
Strength:- | 50 mg, 500 mg |
Form:- | Extended-Release Tablets |
Reference Brands:- | Depakote ER®(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Divalproex Extended-Release (Depakote ER) is a CNS medication used for epilepsy, bipolar disorder, and migraines. Available in 250 mg and 500 mg tablets in the US and EU, it supports once-daily dosing. A strategic neurotherapy product for B2B sourcing with global demand and regulatory compliance.
Divalproex Extended-Release (ER) is a widely prescribed anticonvulsant and mood stabilizer used to treat epilepsy, bipolar disorder, and migraine prophylaxis. This formulation ensures sustained drug release, offering once-daily dosing and improved patient compliance. Marketed in the US under Depakote ER and available across the EU in multiple generic and branded forms, Divalproex ER is manufactured in strengths of 250 mg and 500 mg. Its versatility in neuropsychiatric and neurological conditions makes it a key product for global pharmaceutical sourcing. Ideal for B2B buyers looking to expand in CNS therapeutics, Divalproex ER meets stringent regulatory and quality standards.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications